Form D · Biotechnology
Sensible Biotechnologies, Inc.
Oxford, Oxfordshire, X0 · CIK 0001964363
Offering snapshot reported Sep 2, 2026 · SEC filing
- Reported sold
- $13.5M Offering amount: $15M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 2, 2026 | Initial | $13,518,941 | No comparison | 15 | SEC filing |
| Feb 21, 2023 | Initial | $1,829,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-596217
Source: Form D, filed Sep 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Miroslav Gasparek | Director, Executive |
| Vishal Gulati | Director |
| Marian Kupculak | Director, Executive |
| Joel Schoppig | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Osford Brookes Enterprise Hub Headington Road
Oxford, Oxfordshire, X0, OX3 0BP
Phone: 44 7599 496 330
Oxford, Oxfordshire, X0, OX3 0BP
Phone: 44 7599 496 330